To purchase Allergan, AbbVie sells $30B worth of bonds — 4 insights

AbbVie made the fourth largest corporate bond sale of all time when it sold $30 billion worth of bonds to partially finance its $83 billion takeover of Allergan, the Financial Times reports.

Advertisement

What you should know:

1. AbbVie split the bond offering across 10 offerings, with maturity rates between 18 months and 30 years.

2. It was the largest bond offering since CVS raised $40 billion to take over Aetna.

3. High demand for the bonds among traders will reduce how much AbbVie has to borrow to fund the rest of its acquisition.

4. AbbVie now has a total debt around $90 billion, making it one of the most indebted companies in the world.

More articles on surgery cneters:
CMS to pay for total knees in ASCs, boost ASC payment rate 2.6% in 2020: 4 details
With $60B+ deals this year, what’s in store for private equity in the future?
Texas health system building ASC — 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.